Evidence map›Paper›PMID 29587839›Full record

ArticleBMC complementary and alternative medicine2018

Species identification approach for both raw materials and end products of herbal supplements from Tinospora species.

Maslin Osathanunkul, Rossarin Osathanunkul, Panagiotis Madesis

Abstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maslin OsathanunkulDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, 50200, Thailand. omaslin@gmail.com.ORCID http://orcid.org/0000-0001-6154-2813
Rossarin OsathanunkulFaculty of Economics, Chiang Mai University, Chiang Mai, 50200, Thailand.
Panagiotis MadesisInstitute of Applied Biosciences, Centre for Research & Technology Hellas (CERTH), 57001, Thessaloniki, Greece.

Funding

Thailand Research Fund DBG6080012
6 · The paper itself

Abstract

backgroundNowadays herbal products used in traditional medicine are sold in processed forms and thus morphological authentication is almost impossible. With herbal industry rapidly growing size, consumer safety becomes an important issue that requires special attention. Identification of herbal species in the products is therefore needed.

methodsSequences from the selected regions (matK, rbcL, trnL and ITS1) were retrieved and analysed. Then the most suitable barcode was assessed for discrimination of T. crispa from closely related species by HRM analysis and used in authentication of commercial products.

resultsThe ITS1 barcode was found to be the suitable primer as melting data from the HRM assay proved to be capable of distinguishing T. crispa from its related species. The developed protocol was then employed to authenticate medicinal products in powdered form. HRM analysis of all tested samples here revealed that five out of eight products contained not only the indicated species T. crispa but also other Tinospora, that have a high level of morphological similarity.

conclusionMisrepresentation, poor packaging and inappropriate labeling of the tested medicinal herbal products are thought to be the reason of the results here. Using Bar-HRM with the ITS marker lead to success in authenticating the tested herbal products.

Indexed as

Dietary SupplementsDNA, PlantPlant ExtractsDNA Barcoding, TaxonomicTinosporaDNA, PlantPlant ExtractsauthenticationDNA Barcodingherbal productHRMmedicinal plant

Identifiers

PMID29587839
PMCPMC5870811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.